Literature DB >> 300751

Purification and properties of human lymphocyte activating factor (LAF).

G Blyden, R E Handschumacher.   

Abstract

Lymphocyte-activating factor (LAF) has been shown to be produced by LPS-stimulated human adherent cells (monocytes) and peripheral leukocytes, but many non-macrophage cell lines failed to produce LAF. Other macrophage activators including latex microspheres, antigen-antibody complexes, and barium sulfate induce the production of LAF. There is a delay of 6 hr before significant amounts of LAF activity appear in the supernatant medium and maximum activity is found after 12 to 24 hr. Chromatography of concentrated crude supernatant fractions containing LAF activity on Sephadex G-100 gave two peaks of activity (approximately 85,000 and 13,000 daltons). The latter constitutes the major activity and has been purified at least 500-fold with Sephadex G-100, anion exchange, and adsorption chromatography. Optimal stimulation with LAF induces mitosis in 10% of murine thymocytes. The purified activity is sensitive to chymotrypsin and is not affected by treatment with sodium periodate, sulfhydryl reagents, and phenylmethanesulfonylfluoride. The response of thymocytes to LAF decreases with age after 10 weeks and thymocytes obtained from animals injected with cortisone or tumor-bearing animals have an increased responsiveness to LAF.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300751

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Activation of human lymphocytes by supernatants from human thymic epithelium.

Authors:  J M Goust; D H Vesole; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

2.  Growth of murine thymocytes in vitro in chemically defined medium.

Authors:  G W Wood; J H Greenwood; L Mauser
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

3.  Interleukin-1 in malnutrition.

Authors:  P Bhaskaram; B Sivakumar
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

4.  Prostaglandin E inhibition of T-lymphocyte colony formation: a possible mechanism of monocyte modulation of clonal expansion.

Authors:  R S Bockman; M Rothschild
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

5.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

6.  Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity.

Authors:  R H Widen; C A Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Macrophage-derived growth factor for osteoblast-like cells and chondrocytes.

Authors:  L Rifas; V Shen; K Mitchell; W A Peck
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization.

Authors:  P B Bitterman; S I Rennard; G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

9.  Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.

Authors:  J M Zarling; M Shoyab; H Marquardt; M B Hanson; M N Lioubin; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Histocompatibility antigens on astrocytoma cells.

Authors:  H Hirschberg; L I Endresen; P Wikeby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.